Table 2.
Variable | P value | HR (CI) |
---|---|---|
| ||
Gender | ||
Male (n = 130) | 0.017 | 1.46 (1.06 – 1.87) |
Female (n = 30) | ||
| ||
Age | ||
≥60 (n = 50) | 0.050 | 1.32 (1.17 – 2.01) |
<60 (n = 110) | ||
| ||
Etiology of Cirrhosis | ||
HCV (n = 75) | 0.042 | 1.87 (1.31 - 3.76) |
Non-HCV (n = 85) | ||
| ||
Biochemical MELD score at diagnosis | ||
< 15 (n = 111) | 0.013 | 3.14 (1.41 - 4.88) |
≥ 15 (n = 49) | ||
| ||
AFP at diagnosis (ng/dL) | ||
≥ 400 (n = 52) | 0.029 | 2.61 (1.91 – 3.10) |
< 400 (n = 108) | ||
| ||
Outside Milan criteria at diagnosis | ||
Yes (n = 26) | 0.571 | 9.76 (0.19 – 16.71) |
No (n = 134) | ||
| ||
Time on wait list (days) | ||
< 30 days (n = 96) | 0.610 | 1.18 (0.82 - 1.71) |
≥ 30 days (n = 64) | ||
| ||
Locoregional therapy prior to transplantation | ||
Yes (n = 110) | ||
No (n = 50) | 0.058 | 1.39 (0.98 - 1.92) |
| ||
Incidental HCC | ||
Yes (n = 15) | 0.980 | 0.85 (0.08 - 2.77) |
No (n = 145) | ||
| ||
Tumor stage underestimated by pre-operative imaging | 0.781 | 1.42 (0.84 – 2.14) |
Yes (n = 8) | ||
No (n = 152) | ||
| ||
Poorly differentiated tumor on explant | ||
Yes (n = 21) | 0.767 | 1.08 (0.88 – 1.65) |
No (n = 139) | ||
| ||
Any tumor greater than 3cm in diameter | ||
Yes (n = 66) | 0.799 | 1.48 (0.09 – 1.76) |
No (n = 64) | ||
| ||
NLR at time of diagnosis | ||
≥5 (n = 28) | 0.032 | 2.12 (1.41 – 4.62) |
<5 (n = 132) | ||
| ||
Microvascular invasion | ||
Yes (n = 25) | 0.047 | 1.66 (1.39 – 3.70) |
No (n = 135) |